Astec LifeSciences Limited (NSE:ASTEC)

Market Cap	12.69B
Revenue (ttm)	3.78B
Net Income (ttm)	-1.14B
Shares Out	22.28M
EPS (ttm)	-56.74
PE Ratio	n/a
Forward PE	73.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	56,958
Average Volume	83,811
Open	593.60
Previous Close	593.80
Day's Range	565.00 - 595.65
52-Week Range	565.00 - 1,040.00
Beta	-0.26
RSI	25.95
Earnings Date	Jan 30, 2026

About Astec LifeSciences

Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. It also provides herbicides, insec...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1994
• Employees: 555
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ASTEC

Financial Performance

In 2024, Astec LifeSciences's revenue was 3.81 billion, a decrease of -16.86% compared to the previous year's 4.59 billion. Losses were -1.35 billion, 187.1% more than in 2023.